Different Donors Mesenchymal Stromal Cells Secretomes Reveal Heterogeneous Profile of Relevance for Therapeutic Use

Stem Cells and Development

Volumn 26, Issue 3, 2017, Pages 206-214

  Assoni, Amanda ^a   Coatti, Giuliana ^a   Valadares, Marcos C ^a   Beccari, Melinda ^a   Gomes, Juliana ^a   Pelatti, Mayra ^a   Mitne Neto, Miguel ^a,b   Carvalho, Valdemir M ^b   Zatz, Mayana ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b Fleury   (Brazil)

Author keywords

Duchenne muscular dystrophy; jagged 1; mesenchymal stromal cells; proteome; secretome

Indexed keywords

APOPTOSIS; APOPTOSIS ASSAY; ARTICLE; CELL DIFFERENTIATION; CELL FUNCTION; CELL MIGRATION; CELL PLASTICITY; CELL PROLIFERATION; CONTROLLED STUDY; DONOR; DUCHENNE MUSCULAR DYSTROPHY; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; IN VITRO STUDY; MESENCHYMAL STROMA CELL; MYOBLAST; OXIDATION REDUCTION REACTION; PRIORITY JOURNAL; PROTEIN CONTENT; REGULATORY MECHANISM; STEM CELL TRANSPLANTATION; CELL LINE; CELL MOTION; CELL PROTECTION; COCULTURE; CONDITIONED MEDIUM; CYTOLOGY; DRUG EFFECTS; MESENCHYMAL STEM CELL TRANSPLANTATION; METABOLISM; PATHOLOGY; PHARMACOLOGY; SECRETION (PROCESS);

CONDITIONED MEDIUM; PROTEOME;

APOPTOSIS; CELL LINE; CELL MOVEMENT; COCULTURE TECHNIQUES; CULTURE MEDIA, CONDITIONED; CYTOPROTECTION; FEMALE; HUMANS; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMAL CELLS; MUSCULAR DYSTROPHY, DUCHENNE; MYOBLASTS; PROTEOME; TISSUE DONORS;

EID: 85011024570     PISSN: 15473287     EISSN: 15578534     Source Type: Journal    
DOI: 10.1089/scd.2016.0218     Document Type: Article

References (41)

1. Emery AEH. (2002). The muscular dystrophies. Lancet 359:687-695
2. O'Brien KF and LM Kunkel. (2001). Dystrophin and muscular dystrophy: past, present, and future. Mol Genet Metab 74:75-88
3. Muir LA and JS Chamberlain. (2009). Emerging strategies for cell and gene therapy of the muscular dystrophies. Expert Rev Mol Med 11:e18
4. Gang EJ, R Darabi, D Bosnakovski, Z Xu, KE Kamm, M Kyba and RC Perlingeiro. (2009). Engraftment of mesenchymal stem cells into dystrophin-deficient mice is not accompanied by functional recovery. Exp Cell Res 310: 2624-2636
5. Pinheiro CH, JC de Queiroz, L Guimarães-Ferreira, KF Vitzel, RT Nachbar, LG de Sousa, AL de Souza Jr, MT Nunes and R Curi. (2012). Local injections of adiposederived mesenchymal stem cells modulate inflammation and increase angiogenesis ameliorating the dystrophic phenotype in dystrophin-deficient skeletal muscle. Stem Cell Rev 8:363-374
6. Secco M, C Bueno, NM Vieira, C Almeida, M Pelatti, E Zucconi, P Bartolini, M Vainzof, EH Miyabara, OK Okamoto and M Zatz. (2013). Systemic delivery of human mesenchymal stromal cells combined with IGF-1 enhances muscle functional recovery in LAMA2 dy/2j dystrophic mice. Stem Cell Rev 9:93-109
7. Valadares MC, JP Gomes, G Castello, A Assoni, M Pellati, C Bueno, M Corselli, H Silva, P Bartolini, et al. (2014). Human adipose tissue derived pericytes increase life span in Utrn (tm1Ked) Dmd (mdx)/J mice. Stem Cell Rev 10: 830-840
8. Vieira NM, E Zucconi, CR Bueno Jr, M Secco, MF Suzuki, P Bartolini, M Vainzof and M Zatz. (2010). Human multipotent mesenchymal stromal cells from distinct sources show different in vivo potential to differentiate into muscle cells when injected in dystrophic mice. Stem Cell Rev 6: 560-566
9. Kinnaird T, E Stabile, MS Burnett, M Shou, CW Lee, S Barr, S Fuchs and SE Epstein. (2004). Local delivery of marrow-derived stromal cells augments collateral perfusion through paracrine mechanisms. Circulation 109:1543-1549
10. den Haan MC, V-L van Zuylen, NJ Pluijmert, CI Schutte, WE Fibbe, MJ Schalij, H Roelofs and DE Atsma. (2016). Discrepant results of experimental human mesenchymal stromal cell therapy after myocardial infarction: Are animal models robust enough PLoS One 11:e0152938
11. Ciavarella S, A Caselli, AV Tamma, A Savonarola, G Loverro, R Paganelli, M Tucci and F Silvestris. (2015). A peculiar molecular profile of umbilical cord-mesenchymal stromal cells drives their inhibitory effects on multiple myeloma cell growth and tumor progression. Stem Cells Dev 24:1457-1470
12. Guo G, X Sun, C Chen, S Wu, P Huang, Z Li, M Dean, Y Huang, W Jia, et al. (2013). Whole-genome and wholeexome sequencing of bladder cancer identifies frequent alterations in genes involved in sister chromatid cohesion and segregation. Nat Genet 45:1459-1463
13. Estrada R, N Li, H Sarojini, J An, M-J Lee and E Wang. (2009). Secretome from mesenchymal stem cells induces angiogenesis via Cyr61. J Cell Physiol 219: 563-571
14. Lu Y, Y Yuan, X Wang, L Wei, Y Chen, C Cong, S Li, D Long, W Tan, et al. (2008). The growth inhibitory effect of mesenchymal stem cells on tumor cells in vitro and in vivo. Cancer Biol Ther 7:245-251
15. Caplan AI and D Correa. (2012). The MSC: An injury drugstore. Cell Stem Cell 9: 11-15
16. Blaber SP, RA Webster, CJ Hill, EJ Breen, D Kuah, G Vesey and BR Herbert. (2012). Analysis of in vitro secretion profiles from adipose-derived cell populations. J Transl Med 10:172
17. Caplan AI and JM Sorrell. (2015). The MSC curtain that stops the immune system. Immunol Lett 168:136-139
18. Vieira NM, M Valadares, E Zucconi, M Secco, CR Bueno Jr, V Brandalise, A Assoni, J Gomes, V Landini, et al. (2012). Human adipose-derived mesenchymal stromal cells injected systemically into GRMD dogs without immunosuppression are able to reach the host muscle and express human dystrophin. Cell Transplant 21:1407-1417
19. Leriche-Guérin K, LVB Anderson, K Wrogemann, B Roy, M Goulet and JP Tremblay. (2002). Dysferlin expression after normal myoblast transplantation in SCID and in SJL mice. Neuromuscul Disord 12:167-173
20. Jazedje T, AL Ribeiro, M Pellati, HM de Siqueira Bueno, G Nagata, M Trierveiler, EG Rodrigues and M Zatz. (2015). Human mesenchymal stromal cells transplantation may enhance or inhibit 4T1 murine breast adenocarcinoma through different approaches. Stem Cells Int 2015: 796215
21. Wiśniewski JR, MY Hein, J Cox and M Mann. (2014). A ''proteomic ruler'' for protein copy number and concentration estimation without spike-in standards. Mol Cell Proteomics 13:3497-3506
22. Cox J and M Mann. (2008). MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and proteome-wide protein quantification. Nat Biotechnol 26:1367-1372
23. Cox J, MY Hein, CA Luber, I Paron, N Nagaraj and M Mann. (2014). Accurate proteome-wide label-free quantification by delayed normalization and maximal peptide ratio extraction, termed MaxLFQ. Mol Cell Proteomics 13:2513-2526
24. Schwanhaüsser B, D Busse, N Li, G Dittmar, J Schuchhardt, J Wolf, W Chen and M Selbach. (2011). Global quantification of mammalian gene expression control. Nature 473:337-342
25. Vizcáno JA, A Csordas, N Del-Toro, JA Dianes, J Griss, I Lavidas, G Mayer, Y Perez-Riverol, F Reisinger, et al. (2016). 2016 Update of the PRIDE database and its related tools. Nucleic Acids Res 44:D447-D456
26. Huang DW, BT Sherman, R Stephens, MW Baseler, HC Lane and RA Lempicki. (2008). DAVID gene ID conversion tool. Bioinformation 2:428-430
27. Tran C and MS Damaser. (2015). Stem cells as drug delivery methods: Application of stem cell secretome for regeneration. Adv Drug Deliv Rev 82-83:1-11
28. Haidara K, I Morel, V Abaleá, M Gascon Barré and F Denizeau. (2002). Mechanism of tert-butylhydroperoxide induced apoptosis in rat hepatocytes: involvement of mitochondria and endoplasmic reticulum. Biochim Biophys Acta 1542:173-185
29. Magnelli PE, AM Bielik and EP Guthrie. (2011). Identification and characterization of protein glycosylation using specific endo-and exoglycosidases. J Vis Exp e3749
30. Mo M, W Shan, S Wang, Y Zhou, H Li and Y Wu. (2016). Mesenchymal stem cell subpopulations: phenotype, property and therapeutic potential. Cell Mol Life Sci 73:3311-3321
31. Prockop DJ and JY Oh. (2012). Mesenchymal stem/stromal cells (MSCs): role as guardians of inflammation. Mol Ther 20:14-20
32. Kota DJ, B DiCarlo, RA Hetz, P Smith, CS Cox and SD Olson. (2014). Differential MSC activation leads to distinct mononuclear leukocyte binding mechanisms. Sci Rep 4:4565
33. Pereira T, PAS Armada-da Silva, I Amorim, A Rema, AR Caseiro, A Gärtner, M Rodrigues, MA Lopes, PJ Bártolo, et al. (2014). Effects of human mesenchymal stem cells isolated from Wharton's jelly of the umbilical cord and conditioned media on skeletal muscle regeneration using a myectomy model. Stem Cells Int 2014: 376918
34. Kim HY, H Kim, K-W Oh, S-I Oh, S-H Koh, W Baik, MY Noh, KS Kim and SH Kim. (2014). Biological markers of mesenchymal stromal cells as predictors of response to autologous stem cell transplantation in patients with amyotrophic lateral sclerosis; an investigator-initiated trial and in vivo study. Stem Cells 32:2724-2731
35. Tews DS. (2005). Muscle-fiber apoptosis in neuromuscular diseases. Muscle Nerve 32:443-458
36. Mujoo K, VG Sharin, NS Bryan, JS Krumenacker, C Sloan, S Parveen, LE Nikonoff, AY Kots and F Murad. (2008). Role of nitric oxide signaling components in differentiation of embryonic stem cells into myocardial cells. Proc Natl Acad Sci U S A 105:18924-18929
37. Lai Y, J Zhao, Y Yue, NB Wasala and D Duan. (2014). Partial restoration of cardiac function with DPDZ nNOS in aged mdx model of Duchenne cardiomyopathy. Hum Mol Genet 23:3189-3199
38. Circu ML and TY Aw. (2010). Reactive oxygen species, cellular redox systems, and apoptosis. Free Radic Biol Med 48:749-762
39. Sethi T, RC Rintoul, SM Moore, AC MacKinnon, D Salter, C Choo, ER Chilvers, I Dransfield, SC Donnelly, R Strieter and C Haslett. (1999). Extracellular matrix proteins protect small cell lung cancer cells against apoptosis: A mechanism for small cell lung cancer growth and drug resistance in vivo. Nat Med 5:662-668
40. Boudreau N, CJ Sympson, Z Werb and MJ Bissell. (1995). Suppression of ICE and apoptosis in mammary epithelial cells by extracellular matrix. Science 267:891-893
41. Vieira NM, I Elvers, MS Alexander, YB Moreira, A Eran, JP Gomes, JL Marshall, EK Karlsson, S Verjovski-Almeida, et al. (2015). Jagged 1 rescues the Duchenne muscular dystrophy phenotype. Cell 163:1204-1213.